Compliance concerns may be driven largely by the desire to say out of the regulatory spotlight, but it’s also a business strategy, a panel of experts told an audience during this week’s MassDevice.com Big 100 West event in Orange County, Calif.
Or maybe it is. After all, stopping snoring has paid off pretty nicely for the San Diego-based sleep apnea device company, which has a more than 40% share in the growing market for products to diagnose, treat and manage respiratory disorders.
Glooko continues to carve out a niche in the mobile diabetes management space.
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
A key market for the medical device industry showed some strong signs of life today, following sobering economic news out of Europe yesterday.
Japan, the world’s 3rd-largest economy and 2nd-largest medical device market, reported that its gross domestic product grew at an annualized rate of 3.5% during the 1st quarter and is up 0.9% from the previous quarter. Analysts had predicted a 2.8% annualized growth rate and 0.7% growth for the quarter.
MassDevice held its 2nd annual Big 100 Roundtable West event in Newport Beach, Calif., December 11. A group of nearly med-tech executives and stakeholders gathered for an evening of networking, insight into medical device marketing and intimate interviews with David Pyott, CEO of Allergan; Tom Prescott, CEO of Align Technology; James Mazzo, president of Abbott Medical Optics; and Robert Grant, chairman and Strathspey Crown.